AtriCure Enrolls First Patient in Randomized Multi-Center Trial Evaluating Post-Operative Afib

Go back to AtriCure Enrolls First Patient in Randomized Multi-Center Trial Evaluating Post-Operative Afib
AtriCure, Inc. (NASDAQ: ATRC) Delayed: 27.51 +0.21 (0.77%)
Previous Close $27.30    52 Week High $23.24 
Open $27.30    52 Week Low $13.44 
Day High $27.91    P/E N/A 
Day Low $26.94    EPS $-0.45 
Volume 703,863